You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Steroid-Refractory Grade

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Steroid Resistant Acute GVHD Trial in Lyon (inolimomab)

Available
  • Steroid Resistant Acute Graft Versus Host Disease
  • inolimomab
  • Lyon, France
    ElsaLys Biotech
Sep 16, 2021

Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)

Terminated
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Birmingham, Alabama
  • +47 more
Jan 22, 2023

GVHD Trial in Germany, Spain, United States (Apraglutide)

Recruiting
  • GVHD
  • Stanford, California
  • +14 more
Nov 25, 2022

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 20, 2022

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Steroid-refractory Diamond-Blackfan Anemia (DBA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Bitopertin)

Not yet recruiting
  • Steroid-refractory Diamond-Blackfan Anemia (DBA)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2023

Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

Recruiting
  • Graft-versus-host Disease
  • +2 more
  • Mesenchymal stem cells
  • Edeghem, Antwerpen, Belgium
  • +11 more
Sep 19, 2022

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

Ulcerative Colitis Trial (Tofacitinib, Cyclosporine)

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Sep 26, 2022

A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

Refractory Reflux Esophagitis Trial in Xi'an (Trimebutine Maleate, rabeprazole)

Withdrawn
  • Refractory Reflux Esophagitis
  • Xi'an, Shaanxi, China
    Xijing Hosipital of Digestive Disease
Jan 30, 2023

Osteosarcoma in Children Trial (Dinutuximab beta)

Not yet recruiting
  • Osteosarcoma in Children
  • Dinutuximab beta
  • (no location specified)
Sep 23, 2022

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

DLBCL, High-grade B-cell Lymphoma Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • High-grade B-cell Lymphoma
  • Loncastuximab Tesirine
  • (no location specified)
Dec 13, 2022

High-Grade Glioma Trial in New York, Houston, Madison (CLR 131)

Not yet recruiting
  • High-Grade Glioma
  • CLR 131
  • New York, New York
  • +2 more
Nov 3, 2022

Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Recruiting
  • Chronic Graft vs Host Disease
    • Bucheon-Si, Korea, Republic of
    • +9 more
    Jan 27, 2023

    Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

    Recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • Sevilla, Spain
      José Antonio Pérez Simón
    May 20, 2022

    Henoch-Schönlein Purpura, Gastrointestinal Injury, Mycophenolate Mofetil Trial in Guangzhou (MMF)

    Recruiting
    • Henoch-Schönlein Purpura
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jul 18, 2023